Investigation of the relationship between the pelvic floor and sexual dysfunction in women with Sjögren's syndrome.
Sjögren's syndrome
pelvic floor distress
sexual dysfunction
women
Journal
International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
09
07
2020
revised:
14
09
2020
accepted:
21
09
2020
pubmed:
18
10
2020
medline:
12
10
2021
entrez:
17
10
2020
Statut:
ppublish
Résumé
Women with Sjögren's syndrome (SS) may have sexual dysfunctions due to vaginal dryness and may also have pelvic floor problems. The aim of this study was to examine the pelvic floor distress of women with SS with a self-reported questionnaire, to compare this group with healthy individuals, and to examine the relationship between pelvic floor problems and sexual dysfunction. The study included 94 women with SS, aged 47.26 ± 7.56 years, and 94 age-matched healthy women, aged 48.15 ± 8.73 years. The Pelvic Floor Disease Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and Female Sexual Function Scale (FSFI) were used for assessment. The PFDI-20, PFIQ-7, and FSFI scores of the healthy control group were found to be statistically significantly better than those of the primary SS group (Z = -2.69 to -8.03, P = .00). A moderate-high correlation was found between the total and sub-parameters of PFDI-20 and disease duration, the total and sub-parameters of the PFIQ-7 and the pain sub-parameter and total score of the FSFI (r = -0.66 to 0.78, P = .00-.04). According to the study results, as the disease duration increases, the distress increases and this distress has a negative effect on the health-related quality of life of these women. Pelvic floor distress was associated with poor sexual function and pain. From these results, it can be recommended that the methods of pharmacology, education, exercise, relaxation, lifestyle change, and so on for pelvic floor dysfunction and pain in women with SS should be applied together with a multidisciplinary approach.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Women with Sjögren's syndrome (SS) may have sexual dysfunctions due to vaginal dryness and may also have pelvic floor problems. The aim of this study was to examine the pelvic floor distress of women with SS with a self-reported questionnaire, to compare this group with healthy individuals, and to examine the relationship between pelvic floor problems and sexual dysfunction.
METHODS
METHODS
The study included 94 women with SS, aged 47.26 ± 7.56 years, and 94 age-matched healthy women, aged 48.15 ± 8.73 years. The Pelvic Floor Disease Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and Female Sexual Function Scale (FSFI) were used for assessment.
RESULTS
RESULTS
The PFDI-20, PFIQ-7, and FSFI scores of the healthy control group were found to be statistically significantly better than those of the primary SS group (Z = -2.69 to -8.03, P = .00). A moderate-high correlation was found between the total and sub-parameters of PFDI-20 and disease duration, the total and sub-parameters of the PFIQ-7 and the pain sub-parameter and total score of the FSFI (r = -0.66 to 0.78, P = .00-.04).
CONCLUSION
CONCLUSIONS
According to the study results, as the disease duration increases, the distress increases and this distress has a negative effect on the health-related quality of life of these women. Pelvic floor distress was associated with poor sexual function and pain. From these results, it can be recommended that the methods of pharmacology, education, exercise, relaxation, lifestyle change, and so on for pelvic floor dysfunction and pain in women with SS should be applied together with a multidisciplinary approach.
Identifiants
pubmed: 33068320
doi: 10.1111/1756-185X.13998
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1728-1733Informations de copyright
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Références
Oğütcen-Toller M, Gedik R, Gedik S, Göze F. Sjögren’s syndrome: a case report and review of the literature. West Indian Med J. 2012;61(3):305-308. https://doi.org/10.7727/wimj.2011.070
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjögren's syndrome. Autoimmun Rev. 2010;9(5):A305-A310.
Stephenson KR, Meston CM. The conditional importance of sex: exploring the association between sexual well-being and life satisfaction. J Sex Marital Ther. 2015;41(1):25-38.
Tristano AG. The impact of rheumatic diseases on sexual function. Rheumatol Int. 2009;29(8):853-860.
Baer AN, Walitt B. Update on Sjögren syndrome and other causes of sicca in older adults. Rheum Dis Clin. 2018;44(3):419-436.
van Nimwegen JF, van der Tuuk K, Liefers SC, et al. Vaginal dryness in primary Sjogren’s syndrome: a histopathological case-control study. Rheumatology 2020;0:1-10.
Østensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol. 2004;18(2):219-232.
Priori R, Minniti A, Derme M, et al. Quality of sexual life in women with primary Sjögren syndrome. The Journal of rheumatology. 2015;42(8):1427-1431.
Yildiz Ç, Karakuş S, Bozoklu Akkar Ö, Şahin A, Bozkurt B, Yanik A. Primary Sjögren's syndrome adversely affects the female sexual function assessed by the female sexual function index: a case-control study. Arch Rheumatol. 2017;32(2):123-128.
Al-Ezzi MY, Pathak N, Tappuni AR, Khan KS. Primary Sjögren’s syndrome impact on smell, taste, sexuality and quality of life in female patients: A systematic review and meta-analysis. Mod Rheumatol. 2017;27(4):623-629.
van Nimwegen JF, Arends S, van Zuiden GS, Vissink A, Kroese FG, Bootsma H. The impact of primary Sjögren’s syndrome on female sexual function. Rheumatology. 2015;54(7):1286-1293.
Budden AK, te West NI, Sturgess AD, Moore KH. Pelvic floor dysfunction in female Sjögren’s syndrome: an 8-year audit. Int Urogynecol J. 2016;27(9):1367-1373.
Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren’s syndrome. Mod Rheumatol. 2013;23:841-845.
Tsuboi H, Matsumoto I, Wakamatsu E, et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren’s syndrome. Clin Exp Immunol. 2010;162:53-61.
Kovács L, Marczinovitis I, György A, et al. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3 in primary Sjögren’s syndrome. Rheumatology. 2005;44:1021-1025.
Park K, Haberberger RV, Gordon TP, Jackson MW. Antibodies Interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren’s syndrome. Arthritis Rheumatology. 2011;53:1426-2143.
Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther. 1977;3(1):3-9.
Masters WH. Johnson VE. The sexual response cycles of the human male and female: Comparative anatomy and physiology. Sex Behav. 1965:512-534.
Bortolami A, Vanti C, Banchelli F, Guccione AA, Pillastrini P. Relationship between female pelvic floor dysfunction and sexual dysfunction: an observational study. The journal of sexual medicine. 2015;12(5):1233-1241.
Jones KD, Maxwell C, Mist SD, King V, Denman MA, Gregory WT. Pelvic floor and urinary distress in women with fibromyalgia. Pain Management Nursing. 2015;16(6):834-840.
Kaplan PB, Sut N, Sut HK. Validation, cultural adaptation and responsiveness of two pelvic-floor-specific quality-of-life questionnaires, PFDI-20 and PFIQ-7, in a Turkish population. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2012;162(2):229-233.
Celenay ST, Akbayrak T, Kaya S, Ekici G, Beksac S. Validity and reliability of the Turkish version of the Pelvic Floor Distress Inventory-20. Int Urogynecol J. 2012;23(8):1123-1127.
Rosen CB, Heiman J, Leiblum S, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
Oksuz E, Malhan S. Reliability and validity of the Female Sexual Function Index in Turkish population. Sendrom. 2005;17(7):54-60.
Rodgers LJ, Nicewander WA. Thirteen ways to look at the correlation coefficient as a measure of reliability. Am Stat. 1997;42:59-66.
Kamińska A, Futyma K, Romanek-Piva K, Streit-Ciećkiewicz D, Rechberger T. Sexual function specific questionnaires as a useful tool in management of urogynecological patients - Review. European Journal of Obstetric & Gynecology Reproductive Biology. 2019;234:126-130.
Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. American Journal of Obstetric Gynecology. 2001;185(6):1388-1395.
Aschkenazi SO, Goldberg RP. Female sexual function and the pelvic floor. Expert Review of Obstetrics & Gynecology. 2009;4(2):165-178.
Isik H, Isik M, Aynioglu O, et al. Are the women with Sjögren's Syndrome satisfied with their sexual activity? Revista brasileira de reumatologia. 2017;57(3):210-216.